Abbott Laboratories (Pakistan) (KAR:ABOT) Inventories, Raw Materials & Components: ₨8,275 Mil (As of Mar. 2026)


KAR:ABOT Abbott Laboratories (Pakistan) Ltd KAR:ABOT
77 GF Score
Price ₨1,019.35
GF Value ₨1,003.75
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Abbott Laboratories (Pakistan) Inventories, Raw Materials & Components?

Abbott Laboratories (Pakistan) KAR:ABOT +2.41% 77 Inventories, Raw Materials & Components is ₨8,275 Mil as of Mar. 2026. GuruFocus rates KAR:ABOT with a GF Score™ of 77/100 and a GF Value™ of ₨1,003.75 (Fairly Valued). The stock has 2 warning signs investors should review.

Abbott Laboratories (Pakistan)'s inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₨8,275 Mil.

Abbott Laboratories (Pakistan)'s quarterly raw materials declined from Sep. 2025 (₨6,835 Mil) to Dec. 2025 (₨6,425 Mil) but then increased from Dec. 2025 (₨6,425 Mil) to Mar. 2026 (₨8,275 Mil).

Abbott Laboratories (Pakistan)'s annual raw materials increased from Dec. 2023 (₨5,620 Mil) to Dec. 2024 (₨6,360 Mil) and increased from Dec. 2024 (₨6,360 Mil) to Dec. 2025 (₨6,425 Mil).

Abbott Laboratories (Pakistan) Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories (Pakistan)'s Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (Pakistan) Inventories, Raw Materials & Components Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,320.90 3,519.89 5,620.02 6,360.21 6,424.99

Abbott Laboratories (Pakistan) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,094.10 7,361.93 6,835.00 6,424.99 8,275.00
KAR:ABOT
77GF Score
Abbott Laboratories (Pakistan) Ltd KAR:ABOT
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories (Pakistan) Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₨8,275 Mil mean?
Abbott Laboratories (Pakistan) (KAR:ABOT) has a Inventories, Raw Materials & Components of ₨8,275 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Abbott Laboratories (Pakistan) and its competitors.
Is Abbott Laboratories (Pakistan)'s Inventories, Raw Materials & Components too high?
Abbott Laboratories (Pakistan)'s current Inventories, Raw Materials & Components is ₨8,275 Mil. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s Inventories, Raw Materials & Components compare to ZTS and UTHR?
Abbott Laboratories (Pakistan)'s Inventories, Raw Materials & Components of ₨8,275 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Abbott Laboratories (Pakistan) and its competitors. Abbott Laboratories (Pakistan)'s current Inventories, Raw Materials & Components is ₨8,275 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,003.75, compared to a current price of ₨1,019.35 — trading 1.6% above its estimated fair value. The current Inventories, Raw Materials & Components is ₨8,275 Mil. Abbott Laboratories (Pakistan)'s overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current Inventories, Raw Materials & Components is ₨8,275 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be overvalued. The current stock price of ₨1,019.35 is trading 1.6% above its estimated GF Value™ of ₨1,003.75. GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.

Key valuation signals for KAR:ABOT:

  • Inventories, Raw Materials & Components: ₨8,275 Mil
  • GF Value™: ₨1,003.75 vs. price of ₨1,019.35 (1.6% above fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories (Pakistan) Business Description

Address Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
77GF Score

Get the complete analysis for KAR:ABOT

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨1,019.35
Price
₨1,003.75
GF Value